Aroa Biosurgery (ARX.AX) Earnings Analysis

Aroa Biosurgery (ARX.AX) has no confirmed upcoming earnings date. Last quarter (2026-05-26) it beat with EPS 0.0149 AUD vs 0.00416 AUD est (+258.2%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E 32.42.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ARX.AX next report earnings?

No confirmed upcoming earnings date is currently scheduled for ARX.AX. This page updates as the calendar is published.

ARX.AX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-260.0149 AUD0.00416 AUD+258.2%Beat
2025-05-28-0.00069 AUD0.00364 AUD-119%Miss
2024-12-31-0.00069 AUDn/an/an/a
2024-11-26-0.00439 AUD-0.00642 AUD+31.6%Beat
2024-08-02-0.00437 AUDn/an/an/a

Beat rate: 2/3 (67%) over reported quarters with consensus data.

ARX.AX valuation and analyst view

Trailing P/E32.42
Trailing EPS0.01826 AUD
Price / book2.46
Dividend yield0.00%
Market cap0.20B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Aroa Biosurgery (ARX.AX)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for ARX.AX. This page updates as the calendar is published.

Did ARX.AX beat earnings last quarter?

In its 2026-05-26 report, ARX.AX posted EPS of 0.0149 AUD versus a 0.00416 AUD estimate — a beat of 258.2%.

What is ARX.AX's earnings track record?

Over the last 3 reported quarters with consensus data, ARX.AX beat estimates 2 times (67%).

What is ARX.AX's current P/E ratio and EPS?

ARX.AX trades at a trailing P/E of 32.42 on trailing EPS of 0.01826394008321063 AUD.

What do analysts rate ARX.AX?

ARX.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.